Your browser doesn't support javascript.
loading
Older adults with epilepsy and COVID-19: Outcomes in a multi-hospital health system.
Ufongene, Claire; Van Hyfte, Grace; Agarwal, Parul; Goldstein, Jonathan; Mathew, Brian; Navis, Allison; McCarthy, Louise; Kwon, Churl-Su; Gururangan, Kapil; Balchandani, Priti; Marcuse, Lara; Naasan, Georges; Singh, Anuradha; Young, James; Charney, Alexander; Nadkarni, Girish; Jette, Nathalie; Blank, Leah J.
Afiliação
  • Ufongene C; Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY, United States.
  • Van Hyfte G; Department of Neurology, ISMMS, New York, NY, United States; Institute for HealthCare Delivery Science, Department of Population Health Science and Policy, ISMMS, New York, NY, United States.
  • Agarwal P; Department of Neurology, ISMMS, New York, NY, United States; Institute for HealthCare Delivery Science, Department of Population Health Science and Policy, ISMMS, New York, NY, United States.
  • Goldstein J; Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY, United States.
  • Mathew B; Department of Neurology, ISMMS, New York, NY, United States.
  • Navis A; Department of Neurology, ISMMS, New York, NY, United States.
  • McCarthy L; Department of Neurology, ISMMS, New York, NY, United States.
  • Kwon CS; Department of Neurology, Epidemiology, Neurosurgery and the Gertrude H. Sergievsky Center, Columbia University, New York, NY, United States.
  • Gururangan K; Department of Neurology, ISMMS, New York, NY, United States.
  • Balchandani P; BioMedical Engineering and Imaging Institute, ISMMS, New York, NY, United States.
  • Marcuse L; Department of Neurology, ISMMS, New York, NY, United States.
  • Naasan G; Department of Neurology, ISMMS, New York, NY, United States.
  • Singh A; Department of Neurology, ISMMS, New York, NY, United States.
  • Young J; Department of Neurology, ISMMS, New York, NY, United States.
  • Charney A; Department of Psychiatry, ISMMS, New York, NY, United States.
  • Nadkarni G; Department of Medicine, ISMMS, New York, NY, United States.
  • Jette N; Department of Neurology, ISMMS, New York, NY, United States; Institute for HealthCare Delivery Science, Department of Population Health Science and Policy, ISMMS, New York, NY, United States; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Blank LJ; Department of Neurology, ISMMS, New York, NY, United States; Institute for HealthCare Delivery Science, Department of Population Health Science and Policy, ISMMS, New York, NY, United States. Electronic address: leah.blank@mssm.edu.
Seizure ; 114: 33-39, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38039805
ABSTRACT

BACKGROUND:

Coronavirus disease 2019 (COVID-19) is associated with high rates of mortality and morbidity in older adults, especially those with pre-existing conditions. There is little work investigating how neurological conditions affect older adults with COVID-19. We aimed to compare in-hospital outcomes, including mortality, in older adults with and without epilepsy.

METHODS:

This retrospective study in a large multicenter New York health system included consecutive older patients (age ≥65 years) either with or without epilepsy who were admitted with COVID-19 between 3/2020-5/2021. Epilepsy was identified using a validated International Classification of Disease (ICD) and antiseizure medicationbased case definition. Univariate comparisons were calculated using Chi-square, Fisher's exact, Mann-Whitney U, or Student's t-tests. Multivariable logistic regression models were generated to examine factors associated with mortality, discharge disposition and length of stay (LOS).

RESULTS:

We identified 5384 older adults admitted with COVID-19 of whom 173 (3.21 %) had epilepsy. Mean age was significantly lower in those with (75.44, standard deviation (SD) 7.23) compared to those without epilepsy (77.98, SD 8.68, p = 0.007). Older adults with epilepsy were more likely to be ventilated (35.84 % vs. 16.18 %, p < 0.001), less likely to be discharged home (21.39 % vs. 43.12 %, p < 0.001), had longer median LOS (13 days vs. 8 days, p < 0.001), and had higher in-hospital death (35.84 % vs. 28.29 %, p = 0.030) compared to those without epilepsy. Epilepsy in older adults was associated with increased odds of in-hospital death (adjusted odds ratio (aOR), 1.55; 95 % CI 1.12-2.14, p = 0.032), non-routine discharge disposition (aOR, 3.34; 95 % CI 2.21-5.03, p < 0.001), and longer LOS (46.46 % 95 % CI 34 %-59 %, p < 0.001).

CONCLUSIONS:

In models that adjusted for multiple confounders including comorbidity and age, our study found that epilepsy was still associated with higher in-hospital mortality, longer LOS and worse discharge dispositions in older adults with COVID-19 higher in-hospital mortality, longer LOS and worse discharge dispositions in older adults with COVID-19. This work reinforces that epilepsy is a risk factor for worse outcomes in older adults admitted with COVID-19. Timely identification and treatment of COVID-19 in epilepsy may improve outcomes in older people with epilepsy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / COVID-19 Limite: Aged / Humans Idioma: En Revista: Seizure Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / COVID-19 Limite: Aged / Humans Idioma: En Revista: Seizure Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos